Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Reed Hastings says Big Tech should get used to being hated - like Big Pharma
Reed Hastings thinks the tech industry has some Big Pharma energy. During an interview with 'On with Kara Swisher,' released on Monday, the Netflix founder and former co-CEO responded to questions about the unpopularity of Silicon Valley…
Pharma giants Merck, Eli Lilly face earnings health check (MRK:NYSE)
Pharmaceutical giants Merck (MRK) and Eli Lilly (LLY) are scheduled to report third-quarter results on October 29, with analysts expecting a year-on-year earnings decline in both cases. Merck's per share earnings are projected to drop 19% to $2.09…
MAGA Senator Sure Picked Perfect Time to Buy Pharma Stock
Senator Roger Marshall made a conveniently timed stock purchase in 2018—but his position on the Health, Education, Labor, and Pensions, or HELP, Committee could juice the deal even more. Eight years ago on November 8, when he was still a…
Chinese pharma players take center stage at ESMO 2026, highlighting growing global influence
Photo: Hengrui's exhibition booth at ESMO Congress 2026 Chinese-developed cancer drugs achieved a record level of representation at one of the world's leading oncology conferences, from more prominent time slots to higher number of drug…
Piramal Pharma looks to a 'significantly stronger' second half of the year: Nandini Piramal
The company posted a net profit of ₹5 crore for the second quarter (Q2) ended September 30, 2026, compared to a loss of ₹99 crore in the same quarter last year. Its revenue from operations stood at ₹2,617 crore for the quarter…
Schott Poonawalla now becomes Schott Pharma, as it strengthens presence in specialty glass market
Updated - October 28, 2026 at 09:18 PM. Specialty glass company Schott Poonawalla Private Ltd will become Schott Pharma India Private Ltd, from Wednesday - strengthening its connection with German parent Schott Pharma, besides marking a new journey…
3 Big Pharma Earnings Reports to Watch: Eli Lilly, Merck and Gilead
Eli Lilly's EPS estimate collapsed by a third in just 30 days, Merck faces a comparison it cannot repeat, and Gilead is burning through cash fast. Three pharma giants report Thursday, and the results could reshape the sector's outlook for……
IT stocks, Reliance drag markets lower at midday; Pharma outperforms as Fed decision looms
Equity benchmarks pared some of their early losses by mid-session on Wednesday but remained firmly in the red, with information technology stocks and Reliance Industries continuing to weigh on sentiment even as broader markets and select defensives…
Marshall purchased stock in obscure pharma company just before it secured key FDA approval
On November 8, 2018, then-Congressman Roger Marshall (R-KS) and his wife completed a purchase of 1,250 shares of Ionics Life Sciences, a privately held company, according to documents from the Irish Companies Registration Office obtained by Popular…
Spyglass Pharma (NASDAQ:SGP) Sets New 12-Month High - Still a Buy?
Shares of Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) reached a new 52-week high on Wednesday. The stock traded as high as $32.85 and last traded at $33.1310, with a volume of 105,033 shares. The stock had previously closed at $30.90.
NewAmsterdam Pharma (NAMS) Set to Release Quarterly Earnings on Wednesday
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) is projected to release its Q3 2026 results before the market opens on Wednesday, November 4th. Analysts expect the company to announce earnings of ($0.4949) per share and revenue of $7.54 million…
Astellas Bets Up to $1.3 Billion on Cancer Drug Yet to Enter Human Trials
Astellas Pharma Inc. agreed to pay as much as $1.34 billion for rights to an experimental cancer treatment from Melbourne-based Audax Biosciences that has yet to be tested in humans. Audax will receive an upfront payment and potentially another…
Biotechs buck a sluggish IPO market, but investors should tread warily
With all of the excitement around the highly anticipated Anthropic initial public offering, it might be easy to forget that this year hasn't always been smooth sailing for many prospective stock debuts. In September, OpenAI, Anthropic's chief…
Swiss cantons give green light for modernisation of EuroAirport
The project involves the investment of €157 million (CHF145 million) and is aimed at modernising the infrastructure and improving passenger handling. The airport authorities will finance the project, the two Basel cantons said on Tuesday.
Melbourne cancer therapy start-up wins $2b deal with Japan's Astellas
A Melbourne start-up owned by a small group of medical researchers has landed one of Australia's biggest potential biotech licensing deals after Japanese pharmaceutical giant Astellas Pharma agreed to pay up to $2 billion for future rights to…
Receive a Daily briefing on Pharma Industry News
Get Started